Bioventus Inc. (BVS): restructuring charge — Bioventus announces restructuring; expects $4-5M pre-tax costs, $9-10M annual savings

Bioventus Inc.

Restructuring announced Dec 6, 2022 to align cost structure and improve profitability and cash flow.
Pre-tax costs of $4-5M: $3-4M employee severance/benefits, $1M third-party costs. All cash costs.
Restructuring expected to be completed by end of 2023.
Expected annualized cost savings of $9-10M upon completion.

item 2.05

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

Bioventus Inc. announced a restructuring with charges of between $4 million and $5 million of pre-tax costs.

Type: restructuring
Charge: between $4 million and $5 million of pre-tax costs

Exact text from the filing

The Company expects to incur between $4 million and $5 million of pre-tax costs, of which $3 million to $4 million is due to employee severance and benefits, and the remaining $1 million is due to third-parties and other related costs.

View on SEC.gov

Browse all restructurings & charges →

Bioventus Inc. filing history →

Source: SEC EDGAR

accession 0001628280-22-031531

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.